Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Operating Expenses: 2017-2024

Historic Operating Expenses for Arcus Biosciences (RCUS) over the last 8 years, with Dec 2024 value amounting to $588.0 million.

  • Arcus Biosciences' Operating Expenses rose 9.80% to $168.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $615.0 million, marking a year-over-year increase of 5.85%. This contributed to the annual value of $588.0 million for FY2024, which is 28.67% up from last year.
  • According to the latest figures from FY2024, Arcus Biosciences' Operating Expenses is $588.0 million, which was up 28.67% from $457.0 million recorded in FY2023.
  • Arcus Biosciences' 5-year Operating Expenses high stood at $588.0 million for FY2024, and its period low was $202.0 million during FY2020.
  • For the 3-year period, Arcus Biosciences' Operating Expenses averaged around $479.0 million, with its median value being $457.0 million (2023).
  • Data for Arcus Biosciences' Operating Expenses shows a peak YoY soared of 94.78% (in 2020) over the last 5 years.
  • Arcus Biosciences' Operating Expenses (Yearly) stood at $202.0 million in 2020, then skyrocketed by 62.87% to $329.0 million in 2021, then increased by 19.15% to $392.0 million in 2022, then rose by 16.58% to $457.0 million in 2023, then rose by 28.67% to $588.0 million in 2024.